Connect Biopharma Holdings (CNTB) Intangibles (2020 - 2026)

Connect Biopharma Holdings (CNTB) has reported Intangibles for 7 consecutive years, with $43000.0 the latest figure, recorded in Q1 2026.

• Quarterly Intangibles fell 14.0% year-over-year to $43000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $43000.0 (down 14.0% YoY) and the FY2025 annual result came in at $45000.0, down 15.09% from the prior year.
• Intangibles eased to $43000.0 in Q1 2026 per CNTB's latest filing, from $45000.0 in the prior quarter.
• Over the last five years, Intangibles for CNTB reached as high as $79000.0 in Q2 2022 and fell as low as $43000.0 in Q1 2026.
• A 5-year average of $56287.4 and a median of $53000.0 in 2024 frame the typical range for Intangibles.
• Annual changes were most pronounced in 2022 — Intangibles slipped 19.9% — and 2023, when it fell 11.63%.
• Year by year, Intangibles stood at $70161.4 in 2022, then declined by 11.63% to $62000.0 in 2023, then slipped by 14.52% to $53000.0 in 2024, then retreated by 15.09% to $45000.0 in 2025, then dropped by 4.44% to $43000.0 in 2026.
• According to Business Quant data, Intangibles over the past three periods registered $43000.0, $45000.0, and $47000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.